Investigational Site Number : 1560006

Shanghai 200433

1 studies enrolling now · 6 studies all time

What they study most

Bronchiectasis, Chronic Kidney Diseases, Chronic Obstructive Pulmonary Disease, Chronic Rhinosinusitis Without Nasal Polyps, Chronic Sinusitis, Crohn's Disease, Heart Failure, Prurigo Nodularis, Respiratory Disorder, Sinus Disorder, Sinusitis, Type 2 Diabetes Mellitus

Studies at this site

• A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Crohn's Disease. — Recruiting now
• Dupilumab in CRSsNP — Completed
• A Study to Investigate Long-term Safety and Tolerability of Itepekimab in Participants With COPD — Running, not enrolling
• A Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Non-cystic Fibrosis Bronchiectasis — Completed
• Real-World Effectiveness of Dupilumab in Patients With Prurigo Nodularis: An Observational Study — Running, not enrolling
• Effect of Sotagliflozin on Cardiovascular and Renal Events in Participants With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk — Stopped early